JP3922800002
JP3922800002
MOCHIDA PHARMACEUTICAL CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 108.01B EUR | 111.89B EUR | 127.97B EUR |
Enterprise Value | 90.31B EUR | 111.89B EUR | 109.91B EUR |
Valuation Multiples | |||
Trailing P/E | 11.86x | -- | -- |
Forward P/E | 16.43x | -- | -- |
Price to Sales | 0.89x | -- | -- |
Price to Book | 0.77x | -- | 0.91x |
EV/Revenue | 0.74x | -- | -- |
EV/EBITDA | 6.39x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -- | -- | -- |